FDA feedback enables CervoMed to proceed with proposed endpoints, patient enrichment strategy, and other key aspects of Phase 3 trial design to ...
Lewy Body Dementia (LBD) is a brain disease that’s often misunderstood. It’s actually the second most common type of ...
Psychedelics and Parkinson’s may trigger hallucinations through the same system, revealing how fragile the balance is between ...
A study has found a previously known cancer-related drug can also help slow down the symptoms of Parkinson's disease, but ...
TipRanks on MSN
ACADIA Pharmaceuticals Advances Phase 3 Study for Lewy Body Dementia Psychosis Treatment
Detailed price information for Acadia Pharmaceutica (ACAD-Q) from The Globe and Mail including charting and trades.
Many factors contribute to dementia. But the role of particulates — microscopic solids or droplets in the air — is drawing ...
The cumulative use of strong anticholinergics is associated with an increased risk for dementia in a dose-response pattern; ...
The survival rates of people with early onset dementia—diagnosed before the age of 65—vary considerably by clinical type, but ...
It’s the second most common type of dementia, after Alzheimer’s, yet many remain unfamiliar with its challenges. That’s how ...
TipRanks on MSN
CervoMed Gains FDA Alignment for Phase 3 Trial
CervoMed ( ($CRVO) ) has shared an announcement. On November 4, 2025, CervoMed Inc. announced it received alignment from the U.S. FDA on key ...
Is it cheating if your spouse no longer recognises you? Kasia Delgado speaks to those who began a new relationship at the ...
2don MSN
Caregivers Carry A Heavy Burden—For One Family, It Had Very Real Mental And Physical Impacts
In an adapted excerpt from his book, An Exercise in Uncertainty, Jonathan Gluck shares the impact his cancer journey had on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback